Dr. Torang Shatzmiller Sepah M.D.

Torie Sepah, MD is a physician who specializes in the area of psychiatry and is a diplomate of the American Board of Psychiatry and Neurology. There is no American Board of Behavioral Health because that is a made-up term by insurers to justify decades of a two-tier system of care.  I approach psychiatry as a physician first, just as an internist does  primary care.

After all, psychiatry is an actual medical specialty, recognized by the American Board of Medical Specialties as such.   "Behavioral health" and "mental illness"--these are inaccurate terms, loaded with stigma and have allowed people to feel that their symptoms are under volitional control thus treatment is optional, an 'add-on' like a luxurious spa treatment might be. 

When in fact, one's brain is a vital organ connected to all of the other organs. Psychiatry is a medical specialty. There is no shame in seeking treatment for depression or anxiety, just as there should be no shame in treating hypertension. Both are acutally medical diagnoses. As psychiatric diagnosis are treated by physicians--psychiatrists are not mental health professionals who can prescribe.  

Our practice focuses on neuropsychiatry, specifically neurmodulation, a treatment modality that is FDA-approved, extremely safe, covered by by most insurances plans and allows a patient who been suffered with severe depression to finally find relief with fewer and fewer medications. Deep Transmagnetic Stimulation (dTMS) via the Brainsway system is an evidence-based treatment modality for refractory depression that we offer. Patients can experience relief with fewer side effects and in a shorter period of time. Sessions last about 19 minutes after the first mapping session which is longer. There are usually treatments about 4 X a week (only for 19 minutes) over the course of 8-12 weeks. 

We are also only one of two Spravato centers in Pasadena, allowing us to offer another FDA approved treatment for refractory depression (treatment resistant depression), we are an approved Spravato Center (esketamine) and can administer the intranasal formulation and conduct the required follow-up monitoring according to the REMS guidelines.